Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Pennsylvania's Prescription Drug Monitoring Program (PDMP) May 17, 2016.

Slides:



Advertisements
Similar presentations
A Powerful Tool May, 2014 PDMP. pdmp No reportable financial interest.
Advertisements

“Medication Units” (Opioid Treatment Programs) Drug Enforcement Administration James “Jim” Arnold Chief, Policy Unit Office of Diversion Control D E A.
Preventing Prescription Drug Abuse: Laws and Legislation Hollie Hendrikson, MSc Policy Specialist, Health Program.
ILISA B.G. BERNSTEIN, PHARM.D., J.D. U.S. Food and Drug Administration
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015.
VIRGINIA PRESCRIPTION MONITORING PROGRAM C.A.R.E Presentation February 27, 2015 Ralph Orr Director, Virginia Prescription Monitoring Program.
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
2 H. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM Director Center for Substance Abuse Treatment Substance Abuse Mental Health Services Administration.
FUNDING OPPORTUNITIES. BACKGROUND New category of funding in the FY13 Harold Rogers Prescription Drug Monitoring Program Official title is “Category 3:
2015 User Conference Electronic Prescribing of Controlled Substances (EPCS) April 25, 2015 Presented by: Peter Minio Product Manager, Pediatric and Primary.
Prescription Drug Monitoring Program (PDMP) Maryland Alcohol and Drug Abuse Administration.
California State Board of Pharmacy Continuing Education Program Senate Bill 151 (Burton)
Slide 1 Best Practices Working Group Chapter 244 Acts of 2012 Joint Policy Working Group Bureau of Health Care Safety and Quality Director Madeleine Biondolillo,
Richard Z Aramini, PharmD PGY-1 Pharmacy Practice Resident Bay Pines VA Healthcare Center.
Prescription Drug Monitoring Programs: Analysis of State Level Usage Requirements Matthew Penn, JD, Carla Chen, JD Director, Public Health Law Program.
Public Hearing on Proposed Zoning Regulations for Pain Management Clinics Board of County Commissioners May 22, 2012.
Chapter 29 The PMP Not to be confused with 50 Cent’s song.
Ensuring Availability and Preventing Diversion International Pain Policy Fellowship August 7, 2012 David E. Joranson University of Wisconsin Pain & Policy.
LECTURE FOR ASSIGNMENT 1 AND 2
Rachelle S. Mercier, Esq., MPH November 6, PMP – What is it? A system that records schedule II-V medications that patients have been prescribed.
Georgia’s New and Improved PDMP. Greg Reybold, J.D. VP Public Policy & Association Counsel Georgia Pharmacy Association.
Collaborative Pilot Project: Connecting EMRs with the IL PMP to Improve Medication Safety IL Prescription Monitoring Program IHA’s Institute for Innovations.
SCRIPTS South Carolina Reporting & Identification Prescription Tracking System.
Nebraska’s Prescription Drug Monitoring Program What Do I Really Need to Know? Amy Reynoldson, DHHS Kevin C. Borcher, PharmD,NeHII, Inc.
The AMA: Reducing Opioid Abuse in America Patrice A. Harris, MD, MA Board Chair American Medical Association September 2016.
ABC-MAP Act 191 of 2014 September 16, 2016 Pennsylvania’s Prescription Drug Monitoring Program (PA PDMP)
Oregon Prescription Drug Monitoring Program
Incidental Medical Services (IMS) Department of
Medication Assisted Treatment
Assisting the pharmacist
Maryland Prescription Drug Monitoring Program (PDMP)
Brian Sandoval Governor
Georgia Nurse Protocol Agreement
Wireless Access SSID: cwag2017
Do You Know What Your License Allows You To Do?
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Drugs and Prescription Records
Drugs and Prescription Records
Nebraska Prescription Drug Overdose Prevention Program Efforts
Unified Carrier Registration Act of 2005
RECOMMENDATIONS STATE TASK FORCE FOR THE PREVENTION OF HUMAN
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Susan y swart Ed.D, rn, cae Executive director Ana-Illinois
An Overview of the ePDMP
Telepractice Delivery of Services in OASAS Programs.
Prescription Drug Monitoring Program Facts, Figures, and Trends 3rd Quarter 2017 North Dakota Board of Pharmacy Kathy Zahn, CPhT, PDMP Program Administrator.
PMP Advisory Committee
ROOM project Addressing the Opioid Epidemic in the U.P.
Confidential Records and Protected Disclosures
Federal Regulations requirements for opioid prescription course
2018 Policy and Legislative Update February 18, 2018
Recovery Residences - Florida
Prescription Drug Monitoring Program
Oregon Prescription Drug Monitoring Program
Prescription Drug Monitoring Program
Update on APRN Telepractice: The Regulatory Perspective
Controlled Substances
Prescription Drug Monitoring Program
Controlled Substances
Prescription Drug Monitoring Program
National Credentialing Forum 2019 San Diego, CA February
Illinois Prescription Monitoring Program
Ch 18: Pharmacy.
PMP Advisory Committee
Controlled Substances
Minnesota Board of Pharmacy
OSU Controlled Substances Training Module for Researchers
Florida AHRMM Summer Conference Legislative Briefing
Maryland Prescription Drug Monitoring Program (PDMP)
Presentation transcript:

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Pennsylvania's Prescription Drug Monitoring Program (PDMP) May 17, 2016

ABC-MAP Presentation Agenda PDMP background and purpose Pennsylvania's PDMP old vs. new Definitions and requirements Questions

Prescription Drug Monitoring Program Background A statewide electronic database monitoring tool that will gather information about the prescribing and dispensing of controlled substances

Prescription Drug Monitoring Program Purpose Improve the quality of patient care by providing prescribers and dispensers access to information about all controlled substances dispensed to a patient Encourage prescribers to refer addicted patients to a treatment center for evaluation Aid regulatory and law enforcement agencies in the detection and prevention of fraud, drug abuse, and criminal diversion of controlled drugs

STATUS OF PRESCRIPTION MONITORING PROGRAMS California is credited with operation of the first monitoring program in Seventy-six years later, 49 states and D.C. have passed statutes establishing a PDMP. As of December 2014, 49 programs are collecting prescription data and providing authorized users access to that information. The District of Columbia is in the process of adopting regulations, and Missouri has several bills pending in the state legislature that would enact a PDMP. Prescription Drug Monitoring Program

INTERSTATE SHARING OF PRESCRIPTION MONITORING PROGRAM DATA ¹ Oregon will allow direct access to the PDMP to practitioners in CA, ID and WA. ² Pennsylvania provision went into effect June 30, 2015.

Prescription Drug Monitoring Program Current Pennsylvania has a prescription monitoring system in the Office of Attorney General. It collects only Schedule II drug information. Pharmacies are only required to report their dispensations monthly. Prescribers and medical professional do not have access to the current monitoring system. New Pennsylvania is transitioning from the current prescription monitoring system managed by the Office of Attorney General to the Department of Health in the Prescription Drug Monitoring Program office. It collects Schedule II-V controlled substances data. Dispensers are required to submit prescription data within 72 hours of dispensing the controlled substance. Prescribers and medical professionals can have access to the database. They can assign delegates.

Requirements: Dispensers Requirements: Dispensers and pharmacies: o Must electronically submit information to the system for each controlled substance dispensed  Name of prescriber  Prescriber’s DEA number  Date prescription written  Date prescription dispensed  Name, DOB, gender and address of person receiving the prescription  National Drug Code  Quantity and days’ supply  DEA registration number and National Provider Identifier of dispenser  Method of payment for the prescription

Requirements: Prescribers Prescribers: Must query the system: o For each patient the first time a patient is prescribed a controlled substance by the prescriber o If a prescriber believes the patient may be abusing or diverting o Must indicate the information obtained from the system in the patient’s record if the patient is a new patient or if it is determined that the drug should not be prescribed based upon information from the system

Pennsylvania’s PDMP Team Structure Lauren S. Hughes, MD, MPH, MSc, FAAFP Deputy Secretary for Health Innovation Pennsylvania Department of Health Meghna Patel, MHA Director, Prescription Drug Monitoring Program (PDMP) Office Pennsylvania Department of Health Jared Shinabery, MPH Chief Technology Officer, PDMP Office Norman Spotts Statistical Analyst, PDMP Office Epidemiologist TBD Public Health Program Assistant Administrator TBD

Definitions Definitions: Controlled Substance: drug, substance or immediate precursor under the Controlled Substance, Drug, Device and Cosmetic Act or the Controlled Substances Act of 1972, P.L. 233, No. 64

Definitions Dispenser: someone authorized to deliver a controlled substance to a patient by lawful order of a prescriber Exceptions: o Licensed health care facility for use in that facility o Correctional facility o Authorized person who administers a drug o Wholesale distributor o Licensed provider in the LIFE (Living Independence for the Elderly) program o Provider of hospice o Prescriber at a licensed health care facility if the quantity is for no more than five days o Veterinarian

Definitions Prescriber: Person licensed, registered or otherwise authorized to distribute, dispense or administer a controlled substance

ABC-MAP Board Members: Secretary of Health as the chair Secretaries of Human Services, Drug and Alcohol Programs, State and Aging Commissioners of Insurance, Pennsylvania State Police Attorney General Physician General, if Secretary of Health is not a physician

Questions 1)How is the PDMP supposed to work in my practice? 2)How will the state be using the PDMP? 3)What are the expectations of individual physicians? 4)What do I do if a “red flag” pops up about a patient? 5)How well will the PDMP be integrated into my EHR?

Questions QUESTIONS?